Authors: Violette, SM Guan, W Bartlett, C Smith, JA Bardelay, C Antoine, E Rickles, RJ Mandine, E Van Schravendijk, MR Adams, SE Lynch, BA Shakespeare, WC Yang, M Jacobsen, VA Takeuchi, CS Macek, KJ Bohacek, RS Dalgarno, DC Weigele, M Lesuisse, D Sawyer, TK Baron, R

Citation: Sm. Violette et al., Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption, BONE, 28(1), 2001, pp. 54-64

Authors: Sundaramoorthi, R Siedem, C Vu, CB Dalgarno, DC Laird, EC Botfield, MC Combs, AB Adams, SE Yuan, RW Weigele, M Narula, SS

Citation: R. Sundaramoorthi et al., Selective inhibition of Src SH2 by a novel thiol-targeting tricarbonyl-modified inhibitor and mechanistic analysis by H-1/C-13 NMR spectroscopy, BIOORG MED, 11(13), 2001, pp. 1665-1669

Authors: Rollins, CT Rivera, VM Woolfson, DN Keenan, T Hatada, M Adams, SE Andrade, LJ Yaeger, D van Schravendijk, MR Holt, DA Gilman, M Clackson, T

Citation: Ct. Rollins et al., A ligand-reversible dimerization system for controlling protein-protein interactions, P NAS US, 97(13), 2000, pp. 7096-7101

Authors: Bell, MA Adams, SE

Citation: Ma. Bell et Se. Adams, Comparable performance on looking and reaching versions of the A-not-B task at 8 months of age, INFANT BEH, 22(2), 1999, pp. 221-235

Authors: Lynch, BA Minor, C Loiacono, KA van Schravendijk, MR Ram, MK Sundaramoorthi, R Adams, SE Phillips, T Holt, D Rickles, RJ MacNeil, IA

Citation: Ba. Lynch et al., Simultaneous assay of Src SH3 and SH2 domain binding using different wavelength fluorescence polarization probes, ANALYT BIOC, 275(1), 1999, pp. 62-73